4553 — Towa Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Towa Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	32,830	24,257	29,650	45,471	45,306
Net Total Accounts Receivable
Net Total Receivables	50,748	54,392	71,657	71,631	74,002
Total Inventory
Total Other Current Assets
Total Current Assets	166,864	182,990	217,718	247,306	267,343
Net Property, Plant And Equipment	99,873	127,004	153,642	168,423	170,643
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	332,097	371,347	430,653	470,823	475,290
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	115,073	78,529	80,118	87,939	96,867
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	199,928	234,453	274,760	299,198	297,187
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	132,169	136,894	155,893	171,625	178,103
Total Liabilities & Shareholders' Equity	332,097	371,347	430,653	470,823	475,290
Total Common Shares Outstanding